Purpose: Myocardial blood flow (MBF) obtained by dynamic CT perfusion (CTP) has been recently introduced to assess hemodynamic significance of coronary stenosis in coronary artery disease. The diagnostic performance of dynamic CTP MBF is limited due to subjective interpretation of MBF maps and MBF variations caused by physiological, methodological, and technical issues. In this paper, we introduce a novel method to quantify the hypoperfused volume (HPV) in myocardial territories derived from CT angiography (CTA) to overcome the limitations of current dynamic CTP MBF analysis methods. Methods: The diagnostic performance of HPV in classifying significant stenoses was evaluated on 22 patients (57 vessels) that underwent CTA, CTP and invasive fractional flow reserve (FFR). FFR was used as the standard of reference to determine stenosis significance. The diagnostic performance was compared to that of the mean MBF computed in regions manually annotated by an expert (MA-MBF). HPV was derived by thresholding the MBF in myocardial territories constructed from CTA by locating the closest artery. Diagnostic performance was evaluated using leave-one-case out crossvalidation. Inter-observer reproducibility was assessed by performing annotations of coronary seeds (HPV) and manual regions (MA-MBF) with two users. In addition, the influence of different parameter settings on the diagnostic performance of HPV was assessed. Results: Leave-one-case out cross-validation showed that HPV has an accuracy of 72% (58-83%) with sensitivity of 72% (47-90%) and specificity of 72% (58-83%). The accuracy of MA-MBF was 70% (57-82%) with a sensitivity of 50% (26-74%) and a specificity of 79% (64-91%). The Spearman correlation and the kappa statistic was (q = 0.94, j = 0.86) for HPV and (q = 0.72, j = 0.82) for MA-MBF. The influence of parameter settings on HPV based diagnostic performance was not significant. Conclusions: The proposed HPV accurately classifies hemodynamically significant stenoses with a level of accuracy comparable to the mean MBF in regions annotated by an expert. HPV improves inter-observer reproducibility as compared to MA-MBF by providing a more objective criterion to associate the stenotic coronary with the supplied myocardial territory.
INTRODUCTION
Coronary computed tomography angiography (CTA) has become an established non-invasive imaging technique to assess coronary artery disease (CAD). 1 In a CTA scan, a single motion-free 3D reconstruction of the heart and coronary arteries is performed to allow evaluation of coronary stenoses (i.e., narrowing). The severity of a stenosis is however a poor predictor of functional significance, especially in lesions of intermediate severity (30-70% reduction in diameter). 2 The current standard to assess functional significance of a stenosis is fractional flow reserve (FFR). 3 FFR is currently regarded as the decisive parameter for revascularization and is assessed during invasive coronary angiography (ICA) by advancing a pressure wire in the stenotic coronary and measuring the pressure difference across the stenosis.
Dynamic stress myocardial CT perfusion (CTP) is a non-invasive imaging technique recently introduced to quantitate the myocardial blood flow (MBF). 4 In a typical myocardial CTP scan, a time-sequence of cardiac images is acquired at ECG-triggered intervals after a short bolus injection. Time-attenuation curves, describing the temporal contrast concentration, are extracted from the reconstructed sequence and successively processed with mathematical models to calculate the MBF. Bamberg et al. 5 and Rossi et al. 6 demonstrated that the MBF can be used to classify hemodynamically significant stenoses, as defined with FFR, using cut-off values of 75 ml/100 ml/min. Kono et al. 7 showed that the use of MBF relative to a reference MBF calculated in remote regions improves classification performance compared to using the absolute MBF. Absolute MBF quantification is in fact hampered by MBF variations, which might be caused by different physiological conditions 8 and methodological issues such as limited temporal sampling 9 and beam hardening. 10 Kono found an optimal cut-off value of 103 ml/100 ml/min for the absolute MBF and 0.85 for the relative MBF.
The above studies are based on mean MBF values calculated in regions manually annotated on the MBF maps. Based on previous experience, the reader draws a region surrounding the suspected myocardial perfusion defect associated with the coronary stenosis of interest. The association between stenosis and affected myocardium is difficult to reproduce and is prone to errors due to the large variations in the coronary anatomy and poor anatomical information in the MBF map. Kiris ßli et al. introduced a framework for combined visualization of CTA-derived coronaries and 2D perfusion bull's eye map derived from MR 11 and SPECT. 12 Le et al. 13 introduced a method to determine the myocardial territory fed by a coronary by proximity to the coronary vessel. The method was evaluated on radio-opaque polymer casts of porcine hearts imaged with micro-CT. Akira et al. 14 proposed to determine the myocardial area at risk (MAAR) related to a stenosis to predict the MAAR as determined by SPECT perfusion. Their method was based on a voronoi partition of the myocardium from the coronary centerlines. Good correlation of the CTA-derived MAAR with SPECT-derived MAAR was shown, however, the capability of CTA-derived MAAR to predict hemodynamic significance was not investigated.
In this paper, we introduce hypoperfused volume (HPV) as a novel feature for classification of hemodynamically significant stenoses. The HPV measures the volume of hypoperfused tissue in the myocardial territories distal to the suspected stenosis. HPV is computed semi-automatically from dynamic CTP MBF maps and CTA for each coronary vessel thus enabling direct and objective assessment of the stenosis. As the HPV is evaluated in the myocardial territory associated with a stenosis, artifacts (e.g., beam hardening, motion) present elsewhere in the MBF map, have less influence on the stenosis assessment. Furthermore, HPV is derived from the relative MBF thus it is less affected by inter-patient MBF variations. The contributions of this paper are the following: (a) HPV as novel feature for classification of hemodynamically significant stenoses; (b) a semi-automatic method to calculate the HPV from a set of coronary seeds in CTA and a dynamic CTP-MBF map; (c) validation of the HPV as feature for classification of significant stenosis using invasive FFR as reference; (d) evaluation of accuracy and reproducibility of HPV as compared to the current standard: the mean MBF calculated in regions manually annotated by an expert; (e) investigation of the influence of different parameter settings on the diagnostic performance of HPV.
METHOD
The aim of this study was to introduce a novel HPV feature for non-invasive classification of hemodynamically significant stenoses from dynamic CTP-MBF maps. In this section, a semi-automatic method is introduced to calculate HPV from the MBF maps combined with myocardial territories derived from CTA. The abbreviations used in the paper are presented in Table I .
2.A. Study design
Clinical and imaging data were collected from a prospective study performed at Erasmus MC, University Medical Center, Rotterdam. 6 Patients with suspected CAD underwent CTA and dynamic CTP prior to ICA. FFR was measured during the procedure in the suspected stenotic coronary vessels. Inclusion criteria are fully defined in. 6 Subsequently, from the 48 cases of the prospective study, a subset of 22 cases was selected based on availability of at least two vessels with FFR measurements and presence of at least one non-significant stenotic vessel. Cases with three vessel disease were excluded due to lack of reference MBF values. Visual inspection was performed to exclude cases with severe motion artifacts that prevent reliable MBF quantification (section 2.C.4). No such cases were present in the subset.
2.B. Image acquisition
Single phase CTA scans were performed on a dual-source CT system (Definition Flash-Force; Siemens, Forchheim, Germany) using 90 to 100 mL of iopromide (Ultravist, 370 mgI/mL; Bayer, Berlin, Germany), injected at 5 to 6 mL/s, followed by a saline flush of 45 mL at the same rate. b-blockers were administrated in patients with a fast heart rate. Scan parameters were as follows: ECG-triggered spiral scan mode, tube voltage of 100 kV and 370 mAs per rotation. The reconstruction parameters were: slice thickness 0.4 mm, in plane resolution 0.35 mm; medium-smooth cardiac kernel; the optimal cardiac phase was selected automatically by the workstation's software (Syngo Via, Siemens, Forchheim, Germany) and checked visually by looking for maximum sharpness of coronary contours. The optimal phase resulted mostly in mid-diastole or end-systole.
Dynamic CTP was performed 10 min after CTA. After adenosine infusion (140 lg/kg/min for 3 min), a bolus of 50 mL was injected at a rate of 6 mL/s, followed by a 40-mL saline flush. An ECG-triggered axial scan mode with two alternating table positions 4 was used to repetitively cover the left ventricle myocardium during end systole. Scanning parameters were as follows: tube voltage 100 kV (300 mAS per rotation) in 20 patients and 70 kV in two patients. Images were acquired for a period of 30 s while the patient maintained an inspiratory breath hold. CTP images were reconstructed with a 2 mm thickness and in plane resolution of 0.35 mm using a medium-smooth kernel. Prior to MBF calculation, breathing, and cardiac motion was corrected using non-rigid registration. After registration, the left ventricle myocardium was segmented by performing thresholding on a selected frame (i.e., CTP (ref) ) resulting in CTP (mask) . The MBF was calculated in CTP (mask) as the maximum slope of the fitted myocardial time-attenuation curve divided by the maximum arterial input function. The fitting was achieved by parametric deconvolution 4 assuming a two-compartment model. Registration, segmentation and MBF calculation were performed using a dedicated software (Volume Perfusion CT Body; Siemens, Forchheim, Germany).
2.C. Image analysis
In this section, we describe the processing steps to calculate the HPV. The idea behind the HPV is to threshold the MBF in the myocardial territories distal to the coronary stenosis. The main assumption is that hemodynamic significance is associated with larger hypoperfused volumes in the myocardial territories distal to the stenosis. The myocardial territories are determined semi-automatically from CTA by locating the closest coronary within the myocardium. The HPV calculation consists of the following processing steps ( Fig. 1 ): (i) coronary centerlines extraction in CTA; (ii) multi-atlas segmentation of the myocardium in CTA; (iii) determination of myocardial territories in CTA by minimum distance with the coronary centerlines; (iv) registration of the myocardial territories to the MBF map; (v) calculation of the HPV from the registered myocardial territories and the MBF. The HPV is calculated in the main coronary vessels: right coronary artery (RCA), left anterior descending (LAD), and left circumflex (LCX). In the following sections, each step is described in more detail.
2.C.1. Coronary centerlines extraction
The coronary centerlines are extracted from the CTA by applying a semi-automatic extraction algorithm based on the minimum cost path. The workflow for the coronary centerlines extraction consists of:
1. First, as introduced in, 15 a cost image is calculated from CTA using a multiscale vesselness measure 16 modulated with an intensity threshold function. 2. Then, the user defines seeds at the start, bifurcation, and end point of the main coronary vessels according to a modification of the myocardial model defined in 17 ( Fig. 2(a) ). 3. The centerlines are formed by connecting consecutive seeds on the vascular tree through subsegments [see numbered subsegments in Fig. 2(a) ]. Each subsegment is extracted by applying a minimum cost path algorithm on the cost image between consecutive seeds. 15 Each extracted subsegment is represented with a set of ordered points p k,m with subsegment index k 2 1. . .K and point index m 2 1. . .M k, , where K is the number of subsegments and M k the number of points in subsegment k. In case of erroneous vessel detection, manual definition and/or correction of points is performed. 4. Finally, the user selects a 'stenosis point' for each affected main coronary vessel as the most proximal suspected stenosis in the subsegment where FFR was Artifacts removal mask
Mask of hypoperfused voxels before and after morphological opening
Hypoperfused volume in k-th myocardial territory
Affine and elastic transformation measured. The affected myocardium is determined as the territory distal to the 'stenosis point' (Figs. 2(b) and 2(c)) below an MBF threshold (section 2.C.5).
An application enabling the seed annotations and the centerline extractions was implemented in MevisLab (http:// www.mevislab.de/).
2.C.2. Myocardium segmentation
The myocardium is segmented with a validated multi atlas segmentation method. 18 The atlases used in our study were the same used in. 18 The segmentation algorithm and the optimal settings are available at www.bigr.nl/heartin3d/.
2.C.3. Myocardial territories
The myocardial territories are defined as the myocardial areas fed by specific coronary subsegments. We approximate the myocardial territories as the areas which are the closest, in terms of euclidean distance, to the coronary subsegments. The myocardial territory fed by subsegment k is represented by the binary image CTA L k , which is one in the myocardial area where one of the points p k,m is closer than any other point p n,m with n 6 ¼ k, and 0 everywhere else. In practice each voxel is assigned exclusively to one coronary subsegment. The closest point to a voxel is determined using approximate nearest neighbor search. 19 
2.C.4. Registration of myocardial territories to MBF maps
To analyze the MBF within the myocardial territories, the myocardial territories have to be spatially aligned to the MBF map for which we use a non-rigid registration approach. The myocardial territories CTA L k cannot be directly registered to the MBF due to insufficient anatomical features in the MBF. Hence, the CTA image is registered to the CTP (ref) (Fig. 3(b) ) the septum is well visible due to the contrast present in both ventricles whereas in CTA ( Fig. 3(a) ) the septum's detection is challenging due to the low contrast in the right ventricle. This difference in contrast can cause the erroneous registration of the right ventricle into the septum and the subsequent shifting of the septum's border towards the left ventricle. This effect is illustrated in Fig. 3(d) , where the septum's border is moved further towards the left ventricle with respect to the true location indicated by the intersection of the yellow lines ( Fig. 3(c) ).
These challenges are addressed as follows:
1. Non-rigid registration is performed to capture the heart deformation. First, an affine registration is performed to align the center of mass and orientation of the images; second, a non-rigid registration is performed to accurately match myocardial borders and myocardial territories. To avoid large deformations and misplacement of myocardial territories a regularization term is used which accounts for the approximate location of the myocardial territories. 2. The use of the myocardial territories CTA L k in the registration allows localization of the interseptum in both CTA and CTP (ref) thus improving the registration of the septum's border.
To describe our registration method, we first define a registration in general as a minimization problem:
where I f (x) is the intensity of the fixed image at location x, I m (T (x)) is the intensity of the moving image at the transformed location T(x), C is the cost function, and T (Gen) the final transformation. 20 The method to register CTA to CTP (ref) consists of the following steps (see Fig. 4 
where ||Á|| indicates the euclidean distance. In Eq. (3) the closest myocardial territory was retrieved using the signed Maurer distance available in ITK. 21, 22 The resulting myocardial territories CTP L k s are 1 in the area corresponding to the k-th myocardial territory and zero anywhere else. 3. Third, a non-rigid registration of CTA (Aff) to CTP (ref) and of the CTA Fig. 3(c) , where the septum border is correctly registered, with the registration without the SSD[Á] in Fig. 3(d) , where the septum border is displaced toward the left ventricle. The weight k was selected to have the same contribution to the metric from both the MI [Á] and the SSD[Á] terms. Experiments on two testing datasets showed that k = 1 allowed to have a similar contribution from both terms. The resulting T (Ela) was used to obtain the The registrations and the transformations were performed with the elastix package 20 available at http://elastix.isi.uu.nl. The parameter file used for the registration is available at http://elastix.bigr.nl/wiki/index.php/Parameter_file_database. The validation of the registration was performed visually and implicitly in the validation of HPV (section 3) as severe errors in the registration would deteriorate HPV accuracy.
2.C.5. HPV calculation
The HPV vessel is defined as the total hypoperfused volume distal to the stenosis. To calculate this, first the hypoperfused volumes HPV L k related to the individual myocardial territories are obtained and then the territories distal to the stenosis are summed together. The HPV L k s are obtained from MBF as follows (Fig. 5): 1. Artifacts removal: a mask AR (mask) is used to reduce breathing and cardiac motion artifacts in MBF. Cardiac and breathing motion typically causes large and/or inconsistent variations of the CT signal during the dynamic scan which might result in extreme values in MBF. Some of these artifacts are still present after motion correction and after rejection of subjects with severe motion artifacts. AR (mask) selects the voxels not affected by motion by selecting all voxels in the interval: MBF L < MBF < MBF H . In our experiments, MBF L = 20 ml/100 ml/min and MBF H = 220 ml/ 100 ml/min. MBF H is based on the mean MBF in normal tissue and in artifacts at the edge of the myocardium. Most likely due to administration of b-blockers,
the MBF values in our datasets were generally lower than in datasets acquired without b-blockers. (Fig. 5) and then the volume of all resulting non-zero voxels is summed. 
EXPERIMENTS
The aim of our evaluation was to assess the diagnostic performance of HPV for classification of hemodynamically significant stenoses using FFR based classification as reference standard. The diagnostic performance of HPV was compared to that of the mean MBF calculated in regions annotated manually by an expert (MA-MBF). The classification was performed in the RCA, LAD, and LCX. In the following, we describe the measurement of invasive FFR and MA-MBF.
3.A. Invasive FFR
During ICA, angiograms of the left and right coronary arteries were acquired and inspected by the interventional cardiologist to identify suspected coronary lesions. Coronary lesions with diameter narrowing between 30 and 90% were selected to perform FFR. The FFR was measured using a pressure wire (PressureWire, Radi Medical Systems, Uppsala, Sweden) according to the standard clinical protocol 24 and defined as FFR=(arterial pressure at the site distal to the stenosis)/(arterial pressure at the proximal site or aorta). The FFR measurements were performed at maximal hyperemia induced by a continuous intravenous infusion of adenosine (140 lg/kg/min for a minimum of 2 min). The hemodynamic significance of a stenosis was assumed when FFR ≤ 0.8.
3.B. MA-MBF
The MA-MBF was calculated in regions annotated manually by users with previous experience in dynamic CT-MBF analysis. The regions were selected on 2-mm thick short-axis views of the MBF maps. Circular regions of at least 0.5 cm 2 were positioned in each myocardial segment according to a standard 17-segment model. 17 Myocardial segments supplied by the same coronary vessel were considered as part of the same main myocardial territory (i.e., LAD, LCX, and RCA). Within each territory, the myocardial segment with the lowest MBF mean was selected and used in the analysis. Prior to region selection the users inspected the CTA.
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3.C. Statistical analysis
The diagnostic performances of HPV and MA-MBF were evaluated by measuring sensitivity, specificity, and the area under the curve (AUC) of the receiving operating curve (ROC). 25 Continuous variables are presented as mean AE standard deviation or median and 95% confidence interval.
First, we investigated the influence of different parameter settings on the diagnostic performance of the HPV. The investigated parameters were: the reference MBF R (section 2.C.5), the threshold R H and the kernel size of the opening operator O (ker) (section 2.C.5). The investigated R H s were 80%, 90%, 100% of MBF R . For the absolute MBF, the R H s were 80, 90, 100 ml/100 ml/min. The kernel sizes of the opening operator were (2 9 2 9 2) mm 3 , (1 9 1 9 2) mm 3 , and the null kernel (0 9 0 9 0) mm 3 . AUCs were
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Thresholding rMBF<RH calculated for all the combinations of the three settings and the setting yielding the highest AUC (HPV*-setting) was compared to the MA-MBF in terms of sensitivity and specificity. Optimal cut-off values for HPV* and MA-MBF were calculated according to the Youden index. 26 The statistical analysis was performed using MATLAB. 27 Second, leave-one-case out cross-validation was performed to evaluate the capability to assess new cases using settings optimized on previously analyzed cases. In leaveone-out cross-validation 28 , training is performed on all cases except the test case and then the 'trained' model is used to classify the test case. In our validation, each training stage consists in the following: (a) first the HPV is estimated for all combinations of parameter settings similarly as above (MBF R , R H and O (ker) ) (b) for every parameter setting, the ROC is calculated for the estimated HPV and then the cut-off is determined based on the Youden index. (c) among all parameter settings, the setting yielding the highest AUC is selected and used to classify the test case.
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Third, the inter-observer reproducibility of HPV and MA-MBF was assessed by the Spearman correlation coefficient, the kappa statistic and the Bland-Altman plot 28 computed on values obtained by two different users. The setting used for both users was HPV*-setting. The kappa statistic was computed assuming the cut-off of the user who obtained the highest AUC. The users performing the seed annotations had previous experience in cardiac imaging.
RESULTS
The study population included 22 cases with FFR measured in 57 vessels. Among these, 18 were classified as hemodynamically significant (FFR ≤ 0.8) and 39 non-significant (FFR > 0.8). Figure 7 shows results obtained for different parameter settings on the full dataset (22 cases). Figures 7(a)-7(c) . At an optimal cut-off of 12.5 ml, the HPV* estimation achieved a sensitivity and specificity of 83% and 77% (confidence intervals reported in Table II) . At an optimal cut-off of 76.0 ml/100 ml/min, the MA-MBF achieved a sensitivity and specificity of 72% and 77%. Leave-one-case out cross-validation results are reported in Table II . The most recurrent HPV parameter setting (59% of the cases) found by the leave-one-case out cross-validation was HPV-rMBF-M, R H = 90%, O (ker) = (0 9 0 9 0) mm 3 which was consistent with the HPV*-setting. Figures 10(a) and 10(b) show the Bland-Altman plot for HPV* and MA-MBF. The mean difference for HPV* was 0.0 AE 5.0 ml while for MA-MBF it was À1.3 AE 41.9 ml/ 100 ml/min. The mean difference relative to the full range was 0.0% AE 35.4% for HPV* and À1.2% AE 75.4% for MA-MBF. The plots showed no significant bias of the differences between users for both methods. For MA-MBF larger differences between users were observed towards higher MBF values. For the HPV*, no systematic trends between users were observed.
DISCUSSION
HPV was introduced as a novel feature to classify hemodynamically significant stenoses based on dynamic CTP-MBF maps and CTA myocardial territories. In this study, HPV was validated against invasive FFR and additionally its diagnostic performance was compared to that of the mean MBF calculated in regions annotated manually by an expert (MA-MBF).
The main results of our study are: (a) HPV is capable of classifying hemodynamically significant stenoses with accuracy comparable to that of the mean MBF computed in regions annotated by an expert; (b) HPV is more reproducible than MA-MBF.
The confidence intervals of the performance measures were rather large, owing to the limited size of this study. A larger study will be required to investigate the difference in performance of HPV and MA-MBF in more detail. Also, it should be noted that the performance of MA-MBF in our leave-one-case out cross-validation was lower than that obtained in the prospective study. 7 This can be explained by several factors: the selection of cases, the different observer, the different methods to select the cut-off (Youden versus manual) and the different methods to perform the validation: typically evaluation on the full dataset on which the cut-off was selected, as in, 7 gives a more optimistic performance estimate than the leave-one-out cross-validation that we used. In cross-validation, in fact, the cut-off is optimized for each case separately on a smaller dataset.
With respect to diagnostic performance, even though the performances of HPV and MA-MBF were comparable, HPV has the advantage that it can be obtained by non-experts in dynamic CTP-MBF analysis. In fact, HPV is calculated semiautomatically and does not require the extensive expertise needed to interpret the MBF maps, which is a limiting factor for widespread use of dynamic CTP-MBF. The presented results could be obtained by only requiring knowledge of the coronary anatomy in CTA.
Another advantage of HPV as compared to MA-MBF is the higher inter-observer reproducibility which can be attributed to the more objective and systematic criteria to associate the culprit coronary with the affected myocardial territory. In the MA-MBF analysis, this association is performed subjectively by the user who can be influenced by artifacts and/or local MBF variations. In addition, anatomical variations of the coronary tree between cases can make this association even more challenging, because of the different correspondence between myocardial territories and feeding coronary vessels. The time required to place seeds for coronary centerline extraction in HPV was comparable to the time required for the manual annotations in MA-MBF (10-15 min per case) thus HPV does not require additional interaction time.
As concerning the influence of the parameters settings, the analysis showed that most settings do not significantly influence the diagnostic performance of HPV. Only a slight trend towards better performances for small/null kernel sizes was observed suggesting that the opening operator does not improve the performance. For the considered range of settings, the performance of classification based on HPV was comparable to classification based on MA-MBF and additionally, for the optimal estimation HPV*, there was a promising, but not significant, trend towards higher AUC with respect to MA-MBF (0.84 vs 0.75) (P = 0.25). This trend was confirmed visually in the inter-observer reproducibility analysis where a more distinct separation between significant and non-significant stenoses was achieved by HPV. However, due to the limited sample size the difference in performance between the two methods was not significant. In future, a larger population should be analyzed to evaluate whether HPV can significantly improve classification of significant stenoses with respect to current state of the art MA-MBF.
A limitation of the method is the possible assignment of myocardial territories through anatomical structures that were not modeled like the right ventricle. Currently this can result in inaccurate assignment of RCA subsegments (for instance, subsegment 3 in figure 2(b) and (c) ) to left ventricle myocardial territories. A possible remedy could be evaluating the distance exclusively within the myocardium mask and adding the right ventricle to the segmentation. Truncation of small coronary vessels (i.e., with diameter less then 1.5 mm) is another possible source of error. 13 This is caused by the limited signal to noise ratio of current clinical CT scanners thus it will require a technological improvement to be addressed.
CONCLUSION
We introduced semi-automatically derived hypoperfused volume as a novel feature for non-invasive classification of significant stenoses from dynamic CTP-MBF maps and CTA myocardial territories. The feature is extracted with image processing techniques without subjective interpretation and extensive user interaction. The evaluation showed that the proposed feature can accurately classify significant stenoses, as determined by invasive FFR, with comparable accuracy and higher reproducibility than current methods based on manual annotations on MBF maps. These performances were obtained with settings optimized on a dataset of 22 cases from a single center. In future studies, the performances should be evaluated on a larger dataset also including data from different centers. This would allow to verify the robustness of the settings against MBF variations that might occur due to different scanners and different acquisition conditions.
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